or essential thrombocythemia (n = 82; platelet count (PLT) = 675 ± 225 × 109 l−1 mean ± s.d., 51 with JAK2-V617F, 25 with CALR and 6 with MPL mutations). This evidence concerns the gene JAK2 and essential thrombocythemia.